Zainab M. Elsayed

821 total citations
33 papers, 645 citations indexed

About

Zainab M. Elsayed is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Zainab M. Elsayed has authored 33 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 21 papers in Molecular Biology and 4 papers in Toxicology. Recurrent topics in Zainab M. Elsayed's work include Synthesis and biological activity (14 papers), Enzyme function and inhibition (10 papers) and Synthesis and Catalytic Reactions (7 papers). Zainab M. Elsayed is often cited by papers focused on Synthesis and biological activity (14 papers), Enzyme function and inhibition (10 papers) and Synthesis and Catalytic Reactions (7 papers). Zainab M. Elsayed collaborates with scholars based in Egypt, Saudi Arabia and Italy. Zainab M. Elsayed's co-authors include Wagdy M. Eldehna, Hatem A. Abdel‐Aziz, Tarfah Al‐Warhi, Claudiu T. Supuran, Alessio Nocentini, Mahmoud A. El Hassab, Mohammad M. Al‐Sanea, Eslam B. Elkaeed, Rofaida Salem and Moataz A. Shaldam and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Zainab M. Elsayed

29 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zainab M. Elsayed Egypt	16	488	386	84	83	58	33	645
Radwan El‐Haggar Egypt	14	505 1.0×	382 1.0×	96 1.1×	79 1.0×	52 0.9×	28	695
Haytham O. Tawfik Egypt	19	434 0.9×	329 0.9×	83 1.0×	102 1.2×	59 1.0×	56	694
Marwa G. El‐Gazzar Egypt	17	622 1.3×	310 0.8×	79 0.9×	99 1.2×	53 0.9×	42	789
Ghada H. Al-Ansary Egypt	15	513 1.1×	369 1.0×	64 0.8×	109 1.3×	45 0.8×	21	699
G. Bharath Kumar India	19	695 1.4×	286 0.7×	102 1.2×	75 0.9×	63 1.1×	30	888
Aiten M. Soliman Egypt	21	701 1.4×	452 1.2×	49 0.6×	147 1.8×	67 1.2×	34	882
Yassin M. Nissan Egypt	19	749 1.5×	336 0.9×	144 1.7×	53 0.6×	72 1.2×	37	884
Heba S. A. Elzahabi Egypt	17	761 1.6×	252 0.7×	38 0.5×	80 1.0×	97 1.7×	35	912
Nagwa M. Abdel Gawad Egypt	14	591 1.2×	259 0.7×	80 1.0×	50 0.6×	48 0.8×	19	701
Mohamed A. Omar Egypt	15	537 1.1×	235 0.6×	66 0.8×	71 0.9×	66 1.1×	25	656

Countries citing papers authored by Zainab M. Elsayed

Since Specialization

Citations

This map shows the geographic impact of Zainab M. Elsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zainab M. Elsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zainab M. Elsayed more than expected).

Fields of papers citing papers by Zainab M. Elsayed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zainab M. Elsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zainab M. Elsayed. The network helps show where Zainab M. Elsayed may publish in the future.

Co-authorship network of co-authors of Zainab M. Elsayed

This figure shows the co-authorship network connecting the top 25 collaborators of Zainab M. Elsayed. A scholar is included among the top collaborators of Zainab M. Elsayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zainab M. Elsayed. Zainab M. Elsayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eldehna, Wagdy M., Zainab M. Elsayed, Mohamed R. Elnagar, et al.. (2025). Discovery of enaminone-linked benzofuran derivatives as dual VEGFR-2/hCA IX inhibitors exhibiting hypoxia-mediated chemosensitization. RSC Medicinal Chemistry. 17(2). 965–986.

Nafie, Mohamed S., Zainab M. Elsayed, Eman F. Khaleel, et al.. (2025). Triazole-functionalized benzofuran and benzothiophene semicarbazides as novel VEGFR-2-targeted anti-cancer agents. Bioorganic Chemistry. 163. 108702–108702. 3 indexed citations

Elsayed, Zainab M., Ibrahim Taha Radwan, Abdulrahman A. Almehizia, et al.. (2025). Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1‐ b ]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLC. Drug Development Research. 87(1). e70211–e70211.

Eldehna, Wagdy M., Haytham O. Tawfik, Zainab M. Elsayed, et al.. (2025). Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum Cytotoxicity. Pharmaceuticals. 18(11). 1770–1770.

Eldehna, Wagdy M., Simone Giovannuzzi, Zainab M. Elsayed, et al.. (2025). Development of isatin-functionalized benzenesulfonamides as novel carbonic anhydrase II and VII inhibitors with antiepileptic potential. European Journal of Medicinal Chemistry. 292. 117706–117706. 5 indexed citations

Abdulla, Maha‐Hamadien, Zainab M. Elsayed, Moataz A. Shaldam, et al.. (2024). Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments. Bioorganic Chemistry. 151. 107626–107626. 16 indexed citations

Eldehna, Wagdy M., Zainab M. Elsayed, Mahmoud A. El Hassab, et al.. (2024). Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors. International Journal of Biological Macromolecules. 279(Pt 2). 135010–135010. 10 indexed citations

Eldehna, Wagdy M., Haytham O. Tawfik, Maha‐Hamadien Abdulla, et al.. (2024). Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights. Bioorganic Chemistry. 153. 107804–107804. 7 indexed citations

Eissa, Noura G., Wagdy M. Eldehna, Mahmoud A. El Hassab, et al.. (2023). Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: Effect on ocular retention and intraocular pressure. International Journal of Pharmaceutics. 642. 123161–123161. 4 indexed citations

10.

Al‐Warhi, Tarfah, et al.. (2023). Design and synthesis of benzo[b]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis. Archiv der Pharmazie. 357(2). e2300529–e2300529. 3 indexed citations

11.

Elgazar, Abdullah A., Zainab M. Elsayed, Amira Abood, et al.. (2023). Identification of sulphonamide-tethered N -((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2234665–2234665. 17 indexed citations

12.

Al‐Warhi, Tarfah, Hadia Almahli, Zainab M. Elsayed, et al.. (2023). 1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights. Molecules. 28(7). 3203–3203. 16 indexed citations

13.

Eldehna, Wagdy M., Mahmoud A. El Hassab, Ekram H. Mohamed, et al.. (2022). Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors. International Journal of Pharmaceutics. 631. 122537–122537. 13 indexed citations

14.

Eldehna, Wagdy M., Mahmoud A. El Hassab, Zainab M. Elsayed, et al.. (2022). Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity. Scientific Reports. 12(1). 12821–12821. 57 indexed citations

15.

Al‐Warhi, Tarfah, Ahmed M. El Kerdawy, Mohamed A. Said, et al.. (2022). Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Drug Design Development and Therapy. Volume 16. 1457–1471. 24 indexed citations

16.

Shaldam, Moataz A., Alessio Nocentini, Zainab M. Elsayed, et al.. (2021). Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors. International Journal of Molecular Sciences. 22(20). 11119–11119. 27 indexed citations

17.

Eldehna, Wagdy M., Mahmoud A. El Hassab, Mohamed Farès, et al.. (2021). Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis. International Journal of Pharmaceutics. 612. 121369–121369. 17 indexed citations

18.

Elsayed, Zainab M., Wagdy M. Eldehna, Marwa M. Abdel‐Aziz, et al.. (2021). Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistantMycobacterium tuberculosisand bronchitis causing–bacteria. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 384–392. 44 indexed citations

19.

Eldehna, Wagdy M., Alessio Nocentini, Zainab M. Elsayed, et al.. (2020). Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer. ACS Medicinal Chemistry Letters. 11(5). 1022–1027. 55 indexed citations

20.

Alkhaldi, Abdulsalam A. M., Mohammad M. Al‐Sanea, Alessio Nocentini, et al.. (2020). 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies. European Journal of Medicinal Chemistry. 207. 112745–112745. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact